Petefészekrák: vizsgálatok itt: Egyesült Államok
348 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in Egyesült ÁllamokIntensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
- Where
- Pittsburgh
- Életkor
- 18 év and over
- People
- 28
- Run by
- Kalinski, Pawel, MD, PhD
See details and how to joinNCT07634094 - 1/2. fázisTaking peopleA Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Where
- Fairfax, Huntersville, New York, San Antonio
- Életkor
- 18 év and over
- People
- 499
- Run by
- Arvinas Inc.
See details and how to joinNCT07749586 · EU 2026-525614-57-00 - No phaseTaking peopleUse of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
- Where
- Austin, Dallas, Des Moines, Houston, Miami, Minneapolis, Morristown, Oklahoma City, Providence, Rochester, San Antonio
- Életkor
- 50 év to 74 év
- People
- 8000
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT00539162 - 1. fázisTaking peoplePhase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Where
- Atlanta, Charlottesville, Chicago, Columbus, Detroit, Duarte, Hackensack, Indianapolis, Minneapolis, Nashville, New York, Oklahoma City, Palo Alto, Pittsburgh, San Francisco, Tampa, The Bronx
- Életkor
- 15 év and over
- People
- 282 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06276491 - 1/2. fázisTaking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- Fairfax, Grand Rapids, Houston, Pittsburgh, San Antonio, St Louis
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - 2. fázisTaking peopleSecondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
- Where
- Houston
- Életkor
- 18 év and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05123807 - No phaseTaking peopleSpanish Decision Tool for Ovarian Cancer Maintenance Therapy
- Where
- Houston
- Életkor
- 18 év and over
- People
- 70
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06036810 - 1. fázisTaking peopleSerial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
- Where
- Houston
- Életkor
- 18 év and over
- People
- 300
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03604315 - 1. fázisTaking peopleStudy of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Where
- Boston, Charleston, Charlotte, Cleveland, Houston, La Jolla, Los Angeles, Nashville, New York, Pittsburgh, Providence, Sacramento, Tampa
- Életkor
- 18 év and over
- People
- 473 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT04429542 - 1. fázisTaking peopleIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
- Where
- Houston
- Életkor
- 18 év and over
- People
- 54
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05039801 - 1. fázisTaking peopleA Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- Where
- Aurora, Birmingham, Boston, Buffalo, Fort Worth, Fullerton, Greenbrae, La Jolla, Lebanon, New Hyde Park, Newport Beach, New York, San Antonio, St Louis
- Életkor
- 18 év and over
- People
- 234 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06997029 · EU 2025-524334-26-01 - No phaseTaking peopleDeveloping New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- Where
- Brooklyn, Jamaica, New York, Richmond Hill
- Életkor
- 18 év and over
- People
- 445
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04751435 - 1/2. fázisTaking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Boston, Chicago, Houston, La Jolla, Los Angeles, New York, Portland, Richmond, San Antonio, San Francisco
- Életkor
- 18 év to 130 év
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - 1/2. fázisTaking peoplePhase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Where
- Aurora, Boston, Columbus, Detroit, Duarte, Fairfax, Houston, Irvine, La Jolla, Louisville, Portland, Providence
- Életkor
- 18 év to 130 év
- People
- 622 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05797168 · EU 2022-502576-23-00 - 1. fázisTaking peopleA Study of PHST001 in Advanced Solid Tumors
- Where
- Ann Arbor, Beverly Hills, Boston, Chicago, Denver, Durham, Fairfax, Fort Worth, Grand Rapids, Houston, Irving, Lake Success, Los Angeles, Nashville, New Haven, New York, Palo Alto, San Antonio
- Életkor
- 18 év and over
- People
- 426
- Run by
- Pheast Therapeutics
See details and how to joinNCT06840886 - No phaseCsak meghívásosTissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
- Where
- Bethesda
- Életkor
- 18 év and over
- People
- 500
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03762733 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Austin, Bedford, Boston, Charleston, Cleveland, Dallas, Denver, Detroit, Durham, Fairfax, Houston, Irvine, La Jolla, Los Angeles, Madison, Miami, Nashville, Newark, New Haven, New York, Oklahoma City, Orlando, Philadelphia, Pittsburgh, Port Charlotte, Portland, San Antonio, Seattle, York
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 2. fázisTaking peopleFolate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
- Where
- Jacksonville, Rochester, Scottsdale
- Életkor
- 18 év and over
- People
- 78
- Run by
- Mayo Clinic
See details and how to joinNCT06639074 - 2. fázisTaking peopleRepurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
- Where
- Atlanta
- Életkor
- 18 év and over
- People
- 28
- Run by
- Emory University
See details and how to joinNCT05998135 - 2. fázisTaking peopleA Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Where
- Aurora, Austin, Cincinnati, Cleveland, Fairfax, Los Angeles, Minneapolis, Nashville, Oklahoma City, Portland, Providence, Syracuse, Teaneck
- Életkor
- 18 év and over
- People
- 377 worldwide
- Run by
- AbbVie
See details and how to joinNCT07024784 - 1/2. fázisTaking people177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Where
- Dothan, Grand Rapids, Houston, Omaha
- Életkor
- 18 év and over
- People
- 61
- Run by
- Radiopharm Theranostics, Ltd
See details and how to joinNCT07189871 - 2. fázisTaking peopleEvaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
- Where
- Rochester
- Életkor
- 18 év to 50 év
- People
- 98
- Run by
- Mayo Clinic
See details and how to joinNCT07460752 - 2. fázisTaking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Életkor
- 18 év and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - 1. fázisTaking peopleA Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Where
- Fairfax, Maumee, Portland
- Életkor
- 18 év and over
- People
- 74
- Run by
- TwoStep Therapeutics, Inc.
See details and how to joinNCT07814248 - 1. fázisTaking peopleA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Where
- Boston, Charlotte, Duarte, Gilbert, Houston, Jacksonville, Los Angeles, Miami, Milwaukee, Nashville, New Brunswick, Newport Beach, New York, Pittsburgh, Portland, Round Rock, Santa Monica, Tampa, Winston-Salem
- Életkor
- 18 év and over
- People
- 45
- Run by
- AstraZeneca
See details and how to joinNCT05877599